Literature DB >> 16481197

Solid-phase and bead-based cytokine immunoassay: a comparison.

Wilco de Jager1, Ger T Rijkers.   

Abstract

Cytokines and chemoattractive cytokines (chemokines) are present in a wide variety of body fluids such as plasma, cerebrospinal fluid, bronchoaveolar fluid, amniotic fluid, synovial fluid, middle ear effusion fluid, and urine. Cytokines can be detected using classical solid-phase sandwich immunoassays such as enzyme-linked immunosorbent assay (ELISA) or with a bead based multiplex immunoassay (MIA). The physical chemical properties of the different body fluids (such as pH and total protein content) differ, which may have an impact on the outcome of the cytokine assay. Both ELISA as well as MIA cytokine detection systems are constructed by sandwiching the protein of interest between a capture and reporter antibody. When the biological sample contains heterophilic antibodies (such as in patients with auto-immune diseases), these non-specific antibodies can cause false positive results. During pathological conditions, cytokines may be found over a wide concentration range; likewise have to cover this dynamic range in a similar fashion. The correct (statistical) analysis of standard curves and (multiplexed) data are critical for proper interpretation. Classical ELISA based cytokine assays are robust, easy to use and very well suited for measurement of single cytokines. Due to an increased interest in the integral approach to understand biological processes (the omics era), multiplex immunoassays for detection of cytokines and the interpretation of these assays are gaining popularity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16481197     DOI: 10.1016/j.ymeth.2005.11.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  45 in total

Review 1.  Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens.

Authors:  Marta Sanchez-Carbayo
Journal:  Tumour Biol       Date:  2010-01-21

2.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

3.  Sensitive plasma protein analysis by microparticle-based proximity ligation assays.

Authors:  Spyros Darmanis; Rachel Yuan Nong; Maria Hammond; Jijuan Gu; Anders Alderborn; Johan Vänelid; Agneta Siegbahn; Sigrun Gustafsdottir; Olle Ericsson; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  Mol Cell Proteomics       Date:  2009-11-27       Impact factor: 5.911

4.  Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material.

Authors:  Martin Lundberg; Stine Buch Thorsen; Erika Assarsson; Andrea Villablanca; Bonnie Tran; Nick Gee; Mick Knowles; Birgitte Sander Nielsen; Eduardo González Couto; Roberto Martin; Olle Nilsson; Christian Fermer; Jörg Schlingemann; Ib Jarle Christensen; Hans-Jorgen Nielsen; Björn Ekström; Claes Andersson; Mats Gustafsson; Nils Brunner; Jan Stenvang; Simon Fredriksson
Journal:  Mol Cell Proteomics       Date:  2011-01-17       Impact factor: 5.911

Review 5.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

6.  Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).

Authors:  Andrew B Nixon; Herbert Pang; Mark D Starr; Paula N Friedman; Monica M Bertagnolli; Hedy L Kindler; Richard M Goldberg; Alan P Venook; Herbert I Hurwitz
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

Review 7.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 8.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

9.  Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis.

Authors:  Gary Toedter; Karen Hayden; Carrie Wagner; Carrie Brodmerkel
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

10.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

Authors:  Wilco de Jager; Katarzyna Bourcier; Ger T Rijkers; Berent J Prakken; Vicki Seyfert-Margolis
Journal:  BMC Immunol       Date:  2009-09-28       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.